Among the PHLDA family, PHLDA1 might serve as a therapeutic target for several cancers, such as colon, ovarian, and pancreatic cancer, while PHLDA2 might be used as a therapeutic target for esophageal, kidney, and ovarian cancer. This evidence concerns the gene PHLDA2 and familial pancreatic carcinoma.